WHO Cites Decades of Data Against U.S. MMR Separation and Mandate Rollback

President Trump signed an executive order directing review of childhood vaccine mandates and separate administration of measles, mumps, and rubella antigens, with Health Secretary Robert F. Kennedy Jr. overseeing schedule revisions. The WHO responded that such changes ignore continuous global surveillance data confirming combined MMR safety and efficacy. Current U.S. measles incidence has reached the highest level in 35 years, concentrated in under-vaccinated communities.

Observational data from Denmark’s 657,461-child cohort and the U.S. Vaccine Safety Datalink both report no elevated autism risk after MMR exposure. Relative risk ratios remained near 1.0 across follow-up periods exceeding 10 years. Separating doses lacks supporting RCT evidence and extends the window of susceptibility by months, increasing outbreak probability according to compartmental transmission models.

Policy shifts coincide with documented funding cuts to new vaccine platforms and court pauses on prior schedule alterations. Historical patterns from the UK MMR scare show that confidence erosion can persist years after retractions, with coverage drops of 5–10 percentage points in affected regions. International monitoring indicates similar U.S. trends could amplify importations from endemic areas.

Next steps require state-level mandate enforcement data and real-time seroprevalence surveys within 90 days to quantify coverage loss before the 2026–2027 school year.